|
|||||
|
|
Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitis |
|
| Authors: | Francesca Saffioti Davide Roccarina Mette Vesterhus Johannes R Hov William Rosenberg Massimo Pinzani Stephen P Pereira Kirsten M Boberg Douglas Thorburn |
| Institution: | 1. Sheila Sherlock Liver Centre and UCL Institute for Liver and Digestive Health, University College London & Royal Free London NHS Foundation Trust, London, UK;2. Norwegian PSC Research Center, Department of Transplantation Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Oslo, Norway
Department of Clinical Science, University of Bergen, Bergen, Norway;3. Norwegian PSC Research Center, Department of Transplantation Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Oslo, Norway Section of Gastroenterology, Department of Transplantation Medicine, Division of Surgery, Inflammatory Diseases and Transplantation, Oslo University Hospital, Oslo, Norway Institute of Clinical Medicine, University of Oslo, Oslo, Norway |
| Abstract: | |
| Keywords: | cholangiocarcinoma enhanced liver fibrosis score noninvasive markers primary sclerosing cholangitis |